Product Details

Nizacard 500 (Ranolazine Extended-Release Tablets 500 mg) Ranolazine Extended Release Tablets 500 mg

Ranolazine
500 mg
Tablet

ROA

Oral

Applicant Name

Hetero Labs Nigeria Limited

NRN

A4-100804

Status

Active


Composition

Each extended-release tablet contains: Ranolazine 500 mg Excipients: Methacrylic Acid copolymer USP/NF (Eudragit L10055), Microcrystalline cellulose USP/ NF(AvicelPH 200), Hypromellose USP 2910 5CPS, (Methocel E5LV Premium),Sodium Hydrochloride, USP/NF, Purified Water, HIS/USP/Ph.Eur@, Magnesium Stearate, USP/NF (Ligamed MF-2-V- VEG), Opadry II Blue 85F505115, IH  

ATC Code

C01EB18  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

3 x 10's (in PVC/PVDC blister)  

Product Description

Blue colored, oblong shaped film coated tablets debossed with 'R18' on one side and 'H' on the other side 100 NF-PP-338688 NIZACARD 500 (Ranolazine Extended-Release Tablets 500 mg) RANOLAZINE EXTENDED RELEASE TABLETS 500MG Methacrylic Acid copolymer USP/NF (Eudragit L10055), Microcrystalline cellulose USP/ NF(Avicel PH 200), Hypromellose USP 2910 5CPS, (Methocel E5LV Premium),Sodium Hydrochloride, USP/NF, Purified water, HIS/USP/Ph.Eur@, Magnesium stearate, USP/NF (Ligamed MF-2-V- VEG), Opadry II Blue 85F505115, IH. A4-100804 Drugs Imported Products 3*10 Prescription Only Medicine (POM) 11/22/2023 HETERO LABS NIGERIA LIMITED, OGUNAIKE WAY, GRA IKEJA LAGOS M/S. HETERO LABS LIMITED, UNIT III, 22-110, I.D.A, JEEDIMETLA, HYDERABAD, TELANGANA STATE, INDIA., India

Manufacturer Name

Hetero Labs Limited

Manufacturer Country

INDIA  

Approval Date

2024-03-27  

Expiry Date

2029-03-26